Ann: Capital Raise Investor Presentation, page-7

First 7 Last

Share
Profile

Follow
baldynumbers

3,887 Posts.

409

21/10/21

13:01

Post #: 56968174
Share

Originally posted by BoomCrashOffera: ↑

Take your valid point on quarterly slippage between when revenue is booked compared to when cash is received. However - using your rule of thumb formula, cash receipts in 4th Q 21 should have been $6.9 mill vs $5.3 actual (my $5.6 mill was an error)

5 year revenue goal is $100 mill. At 25% gross profit margin - that produces roughly $25 mill gross profit. Below the line costs are already $24.4 mill in FY21 so unless these can be kept the same on 5 years time - company will be still in the red. Cash flow even more in the red given growing working capital and capex requirements.

Continuous revaluation of pina crop is good for the balance sheet and propping up earnings and EBITDA but what’s the current value of immature pina? One has to tend the crop for four more years (arguably longer) until it can be harvested/sold/used - assuming it all gets to maturity.

3rd quarter FY21 company update/report cited $4.9 mill as the prospectus FY21 Sales and Marketing forecast. Unless there’s another prospectus I’m unaware of - the forecast was actually $3.2 mill.

Unless they can outdo competition on taste (not tried Ned but reviews are mixed), success becomes a branding exercise and expansion of distribution channels - but if the product ain’t good - Aussies won’t buy just on the “buy Australian made” appeal.

I am behind the goals of the founders and seeing them succeed as they have been ballsy and sunk a lot of their own capital in, but unfortunately give it low probability. There really was a good reason why there wasn’t a mid-marker high volume Aussie spirit producer IMHO.

Expand

inventory revaluations reek of an attempt to gain interest & movement in SP like LRK has recently been through.

Massive difference in quality and offering... cant even find NEDS bottles to try in my local Dan Murphys and IMO it appears to be primed for RTD market rather than being a product for tasting.

Agave is definitely the prime opportunity here, but your comments are all ringing true to my ears... still very early days for TSI

TSI Price at posting: $1.82 Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BUX

Buxton projects new graphite province discovery at WA Narryer play

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

There are more pages in this discussion • 11 more messages in this thread...

First 7 Last

Add TSI (ASX) to my watchlist

(20min delay)
Last 4.0¢		Change 0.000(0.00%)		Mkt cap ! $13.00M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Ann: Capital Raise Investor Presentation, page-7

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Buxton projects new graphite province discovery at WA Narryer play

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Featured News

Featured News

Ann: Capital Raise Investor Presentation, page-7

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Buxton projects new graphite province discovery at WA Narryer play

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Featured News

Featured News